Atlas Trials

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

Clinical trial NCT00774046 · COMPLETED

Trial details

NCT number
NCT00774046
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic SyndromeAcute Myeloid Leukemia
Start date
2002-12-01
Primary completion
2011-03-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.